from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2714/-

LFCtreatmentdescriptionclass of inhibitor

1.197

Amikacinug/mL Amikacintranslation

2.196

Cap5-10ug/mL Capreomycintranslation

2.201

Rox10-50 ug/mL Roxithromycintranslation

-0.745

SM2-5 ug/mL Streptomycintranslation

-1.286

Tet5-10 ug/mL Tetracyclinetranslation

0.348

Rif0.2-5ug/mL Rifampicintranscription

-0.001

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.682

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.387

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.603

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.477

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.267

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.182

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.504

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.065

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.373

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.086

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.337

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.694

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.078

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.785

KCN5-20 ug/mL Potassium cyaniderespiration

-0.261

NaN30.2-2 mM Sodium aziderespiration

0.198

Nigericin50 uM Nigericinrespiration

1.134

TRC10-150 ug/mL Triclosanrespiration

1.665

TRZ10-25 ug/mL Thioridazinerespiration

1.679

Valinomycin0.5-10 uM Valinomycinrespiration

0.924

ZnSO42 mM ZnSO4respiration

0.375

menadione6-10 ug/mL Menadionerespiration

0.116

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.074

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.106

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.010

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.184

NRP_1Non-replicating persistence stage 1dosRassociated

0.352

Amp0.2mg/mL AmpicillincellWall

0.146

Cephalexin20-100 ug/mL CephalexincellWall

0.333

Cerulenin0.32-5 ug/mL CerulenincellWall

0.119

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.632

EMB10-20 ug/mL EthambutolcellWall

-0.185

Eta12-40 ug/mL EthionamidecellWall

0.506

INH0.2-0.4 ug/mL IsoniazidcellWall

0.534

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.075

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.257

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.483

BZA0.12 mg/mL BenzamidearomaticAmides

-0.629

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.750

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.258

H2O24 mM hydrogen peroxideDNAdamaging

-0.329

Levo10 ug/mL LevofloxacinDNAdamaging

-1.059

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.057

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.460

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.680

UVUV-irradiationDNAdamaging

-0.110

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.019

Antimycin12.5-50 ug/mL Antimycin A?

0.035

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.187

PA_110-50 ug/mL Antitubercular compound PA-1?

0.223

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.669

PA8240.2-2 ug/mL PA-824?

-0.723

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.741

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.464

Verapamil50 uM Verapamil?

0.232

mercaptoethanol2 mM 2-Mercaptoethanol?

0.097

methoxatin10-20 ug/mL Methoxatin?